Alembic Pharmaceuticals Limited (APLLTD) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.076x

Based on the latest financial reports, Alembic Pharmaceuticals Limited (APLLTD) has a cash flow conversion efficiency ratio of 0.076x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs4.03 Billion ≈ $43.57 Million USD) by net assets (Rs53.16 Billion ≈ $574.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Alembic Pharmaceuticals Limited (APLLTD) liquidity interval to measure how many days the company can operate on defensive assets alone.

Alembic Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Alembic Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Alembic Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alembic Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Icade SA PA:ICAD	0.064x
City Union Bank Limited NSE:CUB	-0.382x
Galapagos NV F:GXEA	-0.025x
Stagwell Inc NASDAQ:STGW	-0.035x
GS Engineering & Construction KO:006360	0.011x
Enviri Corporation NYSE:NVRI	0.130x
Sparebank 1 Nord-Norge OL:NONG	0.132x
Dianguang Explosion-proof Technology Co Ltd SHE:002730	-0.019x

Annual Cash Flow Conversion Efficiency for Alembic Pharmaceuticals Limited (2011–2025)

The table below shows the annual cash flow conversion efficiency of Alembic Pharmaceuticals Limited from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Alembic Pharmaceuticals Limited.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs51.90 Billion ≈ $561.23 Million	Rs879.70 Million ≈ $9.51 Million	0.017x	-89.83%
2024-03-31	Rs48.18 Billion ≈ $521.07 Million	Rs8.03 Billion ≈ $86.86 Million	0.167x	+0.64%
2023-03-31	Rs43.70 Billion ≈ $472.65 Million	Rs7.24 Billion ≈ $78.29 Million	0.166x	+57.07%
2022-03-31	Rs52.38 Billion ≈ $566.42 Million	Rs5.52 Billion ≈ $59.73 Million	0.105x	-63.48%
2021-03-31	Rs50.67 Billion ≈ $547.97 Million	Rs14.63 Billion ≈ $158.26 Million	0.289x	+105.16%
2020-03-31	Rs31.90 Billion ≈ $345.04 Million	Rs4.49 Billion ≈ $48.57 Million	0.141x	-52.88%
2019-03-31	Rs27.18 Billion ≈ $293.94 Million	Rs8.12 Billion ≈ $87.81 Million	0.299x	+112.32%
2018-03-31	Rs22.20 Billion ≈ $240.13 Million	Rs3.12 Billion ≈ $33.79 Million	0.141x	-7.37%
2017-03-31	Rs19.01 Billion ≈ $205.61 Million	Rs2.89 Billion ≈ $31.23 Million	0.152x	-73.87%
2016-03-31	Rs16.01 Billion ≈ $173.09 Million	Rs9.30 Billion ≈ $100.62 Million	0.581x	+199.39%
2015-03-31	Rs8.85 Billion ≈ $95.67 Million	Rs1.72 Billion ≈ $18.58 Million	0.194x	-44.47%
2014-03-31	Rs6.76 Billion ≈ $73.06 Million	Rs2.36 Billion ≈ $25.55 Million	0.350x	-33.59%
2013-03-31	Rs5.03 Billion ≈ $54.39 Million	Rs2.65 Billion ≈ $28.64 Million	0.527x	+47.78%
2012-03-31	Rs3.95 Billion ≈ $42.72 Million	Rs1.41 Billion ≈ $15.22 Million	0.356x	+9.39%
2011-03-31	Rs2.95 Billion ≈ $31.93 Million	Rs961.81 Million ≈ $10.40 Million	0.326x	--

About Alembic Pharmaceuticals Limited

NSE:APLLTD India Drug Manufacturers - Specialty & Generic

Market Cap

$1.59 Billion

Rs147.36 Billion INR

Market Cap Rank

#7135 Global

#338 in India

Share Price

Rs749.70

Change (1 day)

+0.48%

52-Week Range

Rs646.55 - Rs1039.10

All Time High

Rs1247.70